These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 30583881)
1. Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants. Fluit AC; van Gorkum S; Vlooswijk J Diagn Microbiol Infect Dis; 2019 May; 94(1):78-80. PubMed ID: 30583881 [TBL] [Abstract][Full Text] [Related]
2. Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms. Mendes RE; Huband MD; Streit JM; Castanheira M; Flamm RK Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115054. PubMed ID: 32376058 [TBL] [Abstract][Full Text] [Related]
3. In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas. Waites KB; Crabb DM; Liu Y; Duffy LB Antimicrob Agents Chemother; 2016 Dec; 60(12):7502-7504. PubMed ID: 27671057 [TBL] [Abstract][Full Text] [Related]
4. Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014). Pfaller MA; Rhomberg PR; Huband MD; Flamm RK Diagn Microbiol Infect Dis; 2018 Jun; 91(2):179-183. PubMed ID: 29571839 [TBL] [Abstract][Full Text] [Related]
5. Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use. Lewis SA; Altemeier WA Chemotherapy; 1976; 22(5):319-23. PubMed ID: 947710 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Draper MP; Weir S; Macone A; Donatelli J; Trieber CA; Tanaka SK; Levy SB Antimicrob Agents Chemother; 2014; 58(3):1279-83. PubMed ID: 24041885 [TBL] [Abstract][Full Text] [Related]
11. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris. Zhanel G; Critchley I; Lin LY; Alvandi N Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052 [TBL] [Abstract][Full Text] [Related]
12. Lack of doxycycline antimalarial prophylaxis impact on Staphylococcus aureus tetracycline resistance. Mende K; Beckius ML; Zera WC; Yu X; Li P; Tribble DR; Murray CK; Diagn Microbiol Infect Dis; 2016 Oct; 86(2):211-20. PubMed ID: 27460426 [TBL] [Abstract][Full Text] [Related]
13. Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe. Pfaller MA; Rhomberg PR; Huband MD; Flamm RK Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993854 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program. Pfaller MA; Huband MD; Shortridge D; Flamm RK Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378719 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study. Xiao M; Huang JJ; Zhang G; Yang WH; Kong F; Kudinha T; Xu YC BMC Microbiol; 2020 Nov; 20(1):350. PubMed ID: 33198626 [TBL] [Abstract][Full Text] [Related]